Astrid Gnekow - Concepedia

Author

Astrid Gnekow

Also Known As

A Gnekow, A K Gnekow, A. Gnekow, A. K. Gnekow, A.K Gnekow, A.K. Gnekow, Astrid Gnekow, Astrid K Gnekow, Astrid K. Gnekow, Astrid Katharina Gnekow

135

Publications

8.5K

Citations

H-Index

Concepts

All Affiliations

University Hospital Augsburg University of Bonn University of Würzburg Heidelberg University Charité - Universitätsmedizin Berlin

About

Astrid Gnekow is an author at University Hospital Augsburg specializing in medicine, neuro-oncology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	28	5.2K
2	Health Sciences	10	10	933
3	Engineering	1	1	46
4	Public Health	1	1	34
5	Biomedical Engineering	1	1	22

Astrid Gnekow

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
DNA methylation-based classification of central nervous system tumours David Capper, David Jones, Martin Sill, Nature Neuro-oncologyDna Methylation-based ClassificationMedicineEpigenetic ChangeDna Methylation	2018	2.9K
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas Stefan M. Pfister, Wibke G. Janzarik, Marc Remke, Journal of Clinical Investigation GeneticsPathologyMapk Pathway ActivationMolecular GeneticsCell Cycle	2008	511
Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97 Barbara Hero, Thorsten Simon, Ruediger Spitz, Journal of Clinical Oncology	2008	305
Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International society of paediatric oncology (SIOP) and the (German) society of paediatric oncology (GPO): SIOP II C. C. Bailey, Astrid Gnekow, Stefan Wellek, Medical and Pediatric Oncology	1995	303
Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology Astrid Gnekow, F. Falkenstein, S. Hornstein, Neuro-Oncology Surgical OncologyPediatric Brain TumorsPathologyHigh-grade GliomasGlioma	2012	277
Oncogenic FAM131B–BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma Huriye Cin, Claus Meyer, Ricarda Herr, Acta Neuropathologica Alternative MechanismCell RegulationGliomaMedicineCancer Cell Biology	2011	235
Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy Stefan Rutkowski, Nicolas U. Gerber, Katja von Hoff, Neuro-Oncology Surgical OncologyPediatric Brain TumorsGliomaNeuro-oncologyPostoperative Chemotherapy	2009	159
Low Grade Chiasmatic-Hypothalamic Glioma - Carboplatin and Vincristin Chemotherapy Effectively Defers Radiotherapy within a Comprehensive Treatment Strategy Astrid Gnekow, R.-D. Kortmann, Torsten Pietsch, Klinische Pädiatrie	2004	153
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report Astrid Gnekow, David Walker, Daniela Kandels, European Journal of Cancer	2017	141
Intensive chemotherapy improves survival in pediatric high‐grade glioma after gross total resection: results of the HIT‐GBM‐C protocol Johannes Wolff, Pablo Hernáiz Driever, Bernhard Erdlenbruch, Cancer	2009	138

Page 1